These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27537425)

  • 21. Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma.
    Haeggblom L; Attoff T; Hammarstedt-Nordenvall L; Näsman A
    Cancer Med; 2018 May; 7(5):1717-1722. PubMed ID: 29573210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.
    Marklund L; Näsman A; Ramqvist T; Dalianis T; Munck-Wikland E; Hammarstedt L
    Cancer Med; 2012 Aug; 1(1):82-8. PubMed ID: 23342257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.
    Hafkamp HC; Mooren JJ; Claessen SM; Klingenberg B; Voogd AC; Bot FJ; Klussmann JP; Hopman AH; Manni JJ; Kremer B; Ramaekers FC; Speel EJ
    Mod Pathol; 2009 May; 22(5):686-98. PubMed ID: 19305381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
    Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
    Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
    Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
    Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
    Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
    Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
    Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
    Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.
    Evans MF; Matthews A; Kandil D; Adamson CS; Trotman WE; Cooper K
    Head Neck Pathol; 2011 Dec; 5(4):344-8. PubMed ID: 21786153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.
    Klussmann JP; Gültekin E; Weissenborn SJ; Wieland U; Dries V; Dienes HP; Eckel HE; Pfister HJ; Fuchs PG
    Am J Pathol; 2003 Mar; 162(3):747-53. PubMed ID: 12598309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
    Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
    Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.